We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bone Growth Stimulators Help Spinal Fusion Patients Recover

By HospiMedica International staff writers
Posted on 31 Jan 2017
Two new medical devices use a low-level pulsed electromagnetic field (PEMF) to activate and augment the body's natural healing process, promoting post-operative spinal fusion.

The Orthofix CervicalStim and SpinalStim bone growth stimulators are lightweight, all-in-one devices intended as a post-operative adjunct to lumbar and cervical fusion surgical procedures, providing a PEMF signal that covers 360 degrees and up to five levels of fusion. More...
The Spinal-Stim device is indicated as a adjunct to spinal fusion to increase the probability of fusion success and as a nonoperative treatment of salvage of failed spinal fusion, where a minimum of nine months has elapsed since the last surgery.

The Cervical-Stim device is indicated as an adjunct to cervical fusion surgery in patients at high risk for non-fusion; there are no known contraindications. Both the devices work effectively even when worn over clothing or bracing, and have no power cords, thus allowing for unrestricted patient mobility during the treatment. They also include several patient enhancements aimed at improving fit, comfort, and ease of use. Adverse effects may include increased pain, numbness and tingling, headache, migraines and nausea, which may or may not be directly related to use of the device.

Both systems are available with Stim onTrack, an interactive app designed for smartphones and other mobile devices to help patients follow their treatment plan that includes daily reminders and a device usage calendar. The mobile app also includes a feature that enables physicians to receive real-time data on how their patients are adhering to their prescribed treatment protocol. The Stim onTrack app is free of charge and available through the iTunes App Store and Google Play.

“Patient recovery is often dependent on how well they follow the prescription for the device,” said James Ryaby, PhD, chief scientific officer at Orthofix. “Equipping patients with a mobile app to help them adhere to their prescription is an excellent addition to this system while simultaneously enhancing post-surgical care by giving physicians additional data to help personalize follow-up protocols.”

Electricity’s potential to aid bone healing was reported as early as 1841, but it was not until the 1950’s that serious study began. During the 1970s, a new approach for the treatment of delayed fractures was introduced, which employed a very specific biphasic low frequency signal that was applied for non-union/delayed fractures. The first use of electrical stimulation in the lumbosacral region was reported by Alan Dwyer of Australia in 1974.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Medical Adhesive
MED 5570U
New
Disposable Monitor Screen Protectors
Disposable Monitor Screen Protector
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.